Hepatitis C virus (HCV) is considered to be a chronic infection when present for more than 6 months. Chronic HCV affects approximately 200,000 individuals in Australia, commonly causing chronic liver disease, which in some cases leads to death, but in many cases can lead to cirrhosis, decompensated disease or liver cancer.
Eliminating Hepatitis C: What you need to know – QI&CPD – Category 1
Australie
$0
gratuit
QI & CPD - Category 1
6 hrs
Maladie infectieuse
40 Credits
Description du cours
Détails du cours
Date d'expiration : 2019-12-18
Métiers: Médecin
Faculté
Annie Balcomb
(MB, FRACGP, S100 HBV Prescriber
Part time lecturer, Sydney University,
Orange Rural Medical Campus
Orange, NSW),
Associate Professor Stephen Pianko
(MB, PhD
Gastroenterologist and Hepatologist
Monash University
Head of Clinical Trials
Monash Health, Melbourne, Victoria)
Professor Alexander Thompson
(MD, PhD
University of Melbourne
St Vincent’s Hospital, Melbourne, Victoria)
Accréditation
This Active Learning Module has been approved by the The Royal Australian College of General Practitioners QI&CPD Program.Total Points: 40.00 Point(s) (Category 1)
Objectif(s) d'apprentissage
On completion of this program, participants will be able to:
- Describe the burden of HCV disease and its associated complications
- Identify and manage patients with HCV using a simple, evidence-based approach
- Counsel patients regarding the available treatments, including adverse effects and drug interactions
- List the benefits of Sustained Virological Response (SVR) in HCV patients
- Distinguish those patients with HCV infection who require referral to specialist services